GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $503,510 (100.0% shares, 0.0% debt)

Holdings (37)

ADAMAS PHARMACEUTICALS INC 9.0%
Value ($000) $45,524 Shares 2,601,351 Est. Cost $18.31 Unrealized
CONCERT PHARMACEUTICALS INC 7.5%
Value ($000) $37,532 Shares 2,200,000 Est. Cost $17.06 Unrealized
SYNERGY PHARMACEUTICALS DEL 6.7%
Value ($000) $33,662 Shares 7,223,509 Est. Cost $4.54 Unrealized
VNDA VANDA PHARMACEUTICALS INC 6.2%
Value ($000) $31,251 Shares 2,232,238 Est. Cost $10.87 Unrealized +31.1%
RIGEL PHARMACEUTICALS INC 6.0%
Value ($000) $30,140 Shares 9,105,691 Est. Cost $3.31 Unrealized
ZOGENIX INC 5.3%
Value ($000) $26,484 Shares 2,440,959 Est. Cost $11.56 Unrealized
IGNYTA INC 5.2%
Value ($000) $26,413 Shares 3,071,300 Est. Cost $5.55 Unrealized
THERAPEUTICSMD INC 4.9%
Value ($000) $24,914 Shares 3,460,225 Est. Cost $5.85 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 4.8%
Value ($000) $24,248 Shares 560,000 Est. Cost $43.36 Unrealized -1.2%
SAGE THERAPEUTICS INC 4.3%
Value ($000) $21,450 Shares 301,809 Est. Cost $36.69 Unrealized
SAGE THERAPEUTICS INC 4.2%
Value ($000) $21,321 Shares 300,000 Est. Cost $36.69 Unrealized
FOAMIX PHARMACEUTICALS LTD 3.6%
Value ($000) $18,224 Shares 3,681,708 Est. Cost $8.36 Unrealized
DBV TECHNOLOGIES S A 3.4%
Value ($000) $17,114 Shares 485,915 Est. Cost $35.48 Unrealized
AVEXIS INC 3.0%
Value ($000) $15,206 Shares 200,000 Est. Cost $41.71 Unrealized
PTCT PTC THERAPEUTICS INC 2.9%
Value ($000) $14,450 Shares 1,468,521 Est. Cost $12.10 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 2.5%
Value ($000) $12,813 Shares 250,000 Est. Cost $41.87 Unrealized +10.4%
GLOBAL BLOOD THERAPEUTICS IN 2.2%
Value ($000) $11,055 Shares 300,000 Est. Cost $14.45 Unrealized
PARATEK PHARMACEUTICALS INC 2.1%
Value ($000) $10,387 Shares 539,571 Est. Cost $19.25 Unrealized
ACORDA THERAPEUTICS INC 1.8%
Value ($000) $9,083 Shares 432,500 Est. Cost Unrealized
NEURODERM LTD 1.7%
Value ($000) $8,356 Shares 314,724 Est. Cost $26.55 Unrealized
BOVIE MEDICAL CORP 1.6%
Value ($000) $8,157 Shares 3,055,000 Est. Cost $2.83 Unrealized
ACCELERON PHARMA INC 1.6%
Value ($000) $7,941 Shares 300,000 Est. Cost $26.47 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 1.5%
Value ($000) $7,340 Shares 1,000,000 Est. Cost $4.62 Unrealized 0.0%
SUNESIS PHARMACEUTICALS INC 1.3%
Value ($000) $6,305 Shares 1,537,873 Est. Cost $4.14 Unrealized
FIVE PRIME THERAPEUTICS INC 1.1%
Value ($000) $5,613 Shares 155,265 Est. Cost $36.15 Unrealized
BLUEPRINT MEDICINES CORP 1.0%
Value ($000) $4,884 Shares 122,129 Est. Cost $39.99 Unrealized
MYOVANT SCIENCES LTD 1.0%
Value ($000) $4,785 Shares 407,559 Est. Cost $12.34 Unrealized
CONNECTURE INC 0.9%
Value ($000) $4,416 Shares 4,127,232 Est. Cost $9.01 Unrealized
JAZZ JAZZ PHARMACEUTICALS PLC 0.7%
Value ($000) $3,628 Shares 25,000 Est. Cost $130.25 Unrealized 0.0%
AIMMUNE THERAPEUTICS INC 0.5%
Value ($000) $2,661 Shares 122,455 Est. Cost $21.73 Unrealized
RADIUS HEALTH INC 0.4%
Value ($000) $1,933 Shares 50,000 Est. Cost Unrealized
ACORDA THERAPEUTICS INC 0.3%
Value ($000) $1,680 Shares 80,000 Est. Cost Unrealized
CASCADIAN THERAPEUTICS INC 0.3%
Value ($000) $1,565 Shares 377,900 Est. Cost $4.14 Unrealized
TREVENA INC 0.2%
Value ($000) $1,242 Shares 338,292 Est. Cost $5.88 Unrealized
ARADIGM CORP 0.2%
Value ($000) $988 Shares 637,279 Est. Cost $8.85 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 0.1%
Value ($000) $590 Shares 11,517 Est. Cost $41.87 Unrealized +10.4%
STREAMLINE HEALTH SOLUTIONS 0.0%
Value ($000) $155 Shares 151,611 Est. Cost $6.45 Unrealized